retatrutide clinical trials obesity Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide and the Future of

Ozempic is the brand name for semaglutide, which belongs to a group of medicines called GLP-1 medications

This is better than what you get with other weight loss medicines right now

About the Author: Summer Kessel, RD, CSOWM, LDN, is a registered dietitian who specializes in nutrition and behavior change coaching for people on GLP-1 medications

The researchers discovered that small-molecule GLP-1 drugs significantly reduced how much dopamine, a neurotransmitter thats commonly associated with reward-motivated behaviors, was released, essentially changing the animals perception of how rewarding that food is. Gler hopes that his teams discovery can help guide future efforts in designing GLP-1 drugs that target specific parts of the brain, such as the reward center

Who qualifies for using GLP-1 drugs for weight loss

Born Wanderer // Usually Mexico Erick Erick takes on more responsibility